-- 週一,香港股市下跌,投資人在美伊談判破裂後趨於謹慎,而美伊計畫封鎖伊朗港口的消息更加劇了市場的不確定性。 恆生指數下跌232.69點,下跌0.9%,收25,660.85點;恆生中國企業指數下跌52.98點,下跌0.6%,收8,602.06點。 美國總統川普週日表示,美國海軍將開始封鎖霍爾木茲海峽,這將使脆弱的兩週停火協議面臨風險。 美國中央司令部表示,封鎖將於週一開始,所有進出伊朗港口和沿海地區的船隻都將受到影響。 同時,伊朗伊斯蘭革命衛隊警告稱,任何靠近霍爾木茲海峽的軍艦都將被視為違反停火協議,並將遭到堅決回應。 不斷升級的緊張局勢波及大宗商品市場,油價攀升至每桶100美元以上,由於美元走強抑制需求,黃金價格跌至近一周低點。 企業新聞方面,Joy Spreader(港交所代碼:6988)與北京火山引擎技術有限公司合作,在其營運中部署人工智慧技術,股價飆升近99%。 同時,勝利巨人科技(港交所代碼:2476,滬交所代碼:300476)啟動香港上市計劃,擬募資至多175億港元,儘管受到中東局勢波動的影響,仍推進了今年香港規模最大的上市項目之一。
Related Articles
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.